NCT03771560View on ClinicalTrials.gov

Folinic Acid in Autism

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Autism Spectrum Disorder
Interventions
DRUG

folinic acid

subject will take folinic acid daily for 12 weeks

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT03771560 - Folinic Acid in Autism | Biotech Hunter | Biotech Hunter